Pharmaceuticals & Biotechnology

Alkem Laboratories Limited

ISIN: INE540L01014 · Data as of Oct 2026
Share: WhatsApp ✕ X
Search another stock:
Active Funds Holding
68
vs Last Month
-4 funds
Total Value
₹8,700.12 Cr
Avg Weight
8.16%
New Entries
3
Exits
7
ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.
Mid Cap Rank #164
₹39.03 K Cr
Avg Mkt Cap · Jan-Jun 2023 (3yr ago)
→
₹65.71 K Cr
Avg Mkt Cap · Jan-Jun 2026 (latest)
+68.3%
3yr change
SEBI · AMFI Market Cap List
📋 What Changed This Month Alkem Laboratories Limited is currently held by 68 active mutual funds with total exposure of ₹8,700.12 Cr. This month 3 funds entered and 7 funds exited. Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option has the highest allocation at 182%. ↓ Scroll down for full fund list and monthly changes.
Trend

How Has Fund Coverage Changed — Last 5 Months?

Month Funds AUM (Cr) AMCs Status
Oct 2026 REFERENCE 68 ₹8,700 48 / 49
Sep 2026 72 ₹9,555 49 / 49 ✅ Complete
Aug 2026 71 ₹9,134 49 / 49 ✅ Complete
Jul 2026 75 ₹10,108 49 / 49 ✅ Complete
Jun 2026 79 ₹10,174 49 / 49 ✅ Complete

📌 Portfolio changes below are based on Oct 2026 data — the most complete month with 48 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Oct 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

By Category

Which Fund Categories Hold This Stock?

Category Funds Avg Weight Distribution
Equity 24 9.55%
Mid Cap 16 9.24%
Value/Contra 8 16.91%
Multi Cap 4 1.71%
Flexi Cap 4 1.95%
ELSS 4 1.7%
Balanced Advantage 4 0.69%
Multi Asset 3 5.4%
Aggressive Hybrid 1 1.98%
All Holdings

Which 68 Active Funds Hold Alkem Laboratories Limited?

Filter:
Fund ↕ Category ↕ Weight ↕ Value ↕ Change ↕
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Equity 182% ₹165.51 Cr +180.18%
Nippon India Growth Mid Cap Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Mid Cap 129% ₹629.16 Cr +127.73%
Nippon India Value Fund - Direct Plan Growth Plan
Nippon India Mutual Fund
Value/Contra 125% ₹103.14 Cr +124.05%
Nippon India Multi Asset Allocation Fund - Direct Plan - Growth Option
Nippon India Mutual Fund
Multi Asset 15% ₹27.10 Cr +14.85%
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
HDFC Mutual Fund
Equity 4.75% ₹173.98 Cr +0.11%
DSP Healthcare Fund - Direct Plan - Growth
DSP Mutual Fund
Equity 4.73% ₹176.24 Cr -0.02%
ICICI Prudential Healthcare Fund
ICICI Prudential Mutual Fund
Equity 4.61% ₹327.25 Cr -0.2%
UTI Healthcare Fund - Direct Plan - Growth Option
UTI Mutual Fund
Equity 3.66% ₹52.42 Cr -0.04%
Mirae Asset Healthcare Fund Direct Growth
Mirae Asset Mutual Fund
Equity 3.65% ₹130.08 Cr -0.11%
DSP Multi Cap Fund
DSP Mutual Fund
Multi Cap 3.32% ₹93.03 Cr +0.06%
NJ Flexi Cap Fund
NJ Mutual Fund
Flexi Cap 3.21% ₹82.93 Cr NEW
NJ ELSS Tax Saver Scheme
NJ Mutual Fund
ELSS 3.18% ₹10.25 Cr +0.07%
Bandhan Healthcare Fund - Direct Plan - Growth
Bandhan Mutual Fund
Equity 3.15% ₹10.23 Cr NEW
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option
ITI Mutual Fund
Equity 3.05% ₹8.14 Cr -0.04%
BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH
Bajaj Finserv Mutual Fund
Equity 2.84% ₹11.88 Cr -0.12%
Explore More
← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.